AI assistant
Sending…
Fulgent Genetics, Inc. — Director's Dealing 2020
Dec 22, 2020
32553_dirs_2020-12-22_44c42e7b-4449-43ef-80e8-5256dd96c82b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-12-15
Reporting Person: Ming Hsieh Trust (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7895115 | Direct |
Footnotes
F1: The reported securities were transferred to the reporting person for no consideration by Ming Hsieh, the President, Chief Executive Officer and Board of Directors of the issuer, for estate planning purposes. Mr. Hsieh is the trustee of the reporting person and possesses the sole voting and dispositive power with respect to the reported securities.
More from Fulgent Genetics, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 26